Pharmaceutical manufacturer for Gefapixant

Dipharma is a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients, with more than 500 employees, 4 cGMP plants and commercial offices in Italy, U.S.A. and China. We put our heart and soul into supporting our customers with a competitive and highly proactive approach, backed by 75 years of experience in safely handling hazardous chemical processes using state-of-the-art technologies. As a third-generation family-owned company, we have a long history of stability, commitment and financial solidity. We know how to deliver on creative innovation and we understand the critical importance of matching timelines, while operating in full respect of international regulations, Intellectual Property and third-party patents.

Established in May 2012, this company is a wholly-owned subsidiary of Shandong Bestcomm Pharmaceutical CO., Ltd. It is situated in the Qihe Economic Development Zone, which is renowned as the 'Pearl of the Yellow River'. The company has constructed API pilot test, production base, and formulation production base in adherence to European, American, and global standards. Currently, there are 13 production lines for oral solid preparations, oral liquid preparations, and API. The company is also intensifying its efforts in establishing preparation workshops for small-volume injections, soft capsules, eye drops, topical medicines, and an innovative drug R&D center.